No. |
Chromosome Location |
Chromatin state |
Cell line |
Tissue |
1 |
chr2:182703200-182717200 |
Weak transcription |
Pancreas |
Pancrea
|
2 |
chr2:182710400-182717800 |
Enhancers |
Primary monocytes fromperipheralblood |
blood
|
3 |
chr2:182712800-182716600 |
Enhancers |
Brain Hippocampus Middle |
brain
|
4 |
chr2:182714000-182719400 |
Weak transcription |
hESC Derived CD184+ Endoderm Cultured Cells |
ES cell derived
|
5 |
chr2:182714600-182719400 |
Weak transcription |
iPS-15b Cell Line |
embryonic stem cell
|
6 |
chr2:182714800-182718200 |
Weak transcription |
Fetal Kidney |
kidney
|
7 |
chr2:182715000-182716800 |
Flanking Active TSS |
Monocytes-CD14+_RO01746 |
blood
|
8 |
chr2:182715000-182717000 |
Enhancers |
Primary hematopoietic stem cells G-CSF-mobilized Male |
--
|
9 |
chr2:182715200-182716400 |
Weak transcription |
Brain Cingulate Gyrus |
brain
|
10 |
chr2:182715200-182717000 |
Enhancers |
Primary hematopoietic stem cells G-CSF-mobilized Female |
--
|
11 |
chr2:182715200-182719000 |
Weak transcription |
H9 Derived Neuronal Progenitor Cultured Cells |
ES cell derived
|
12 |
chr2:182715200-182719400 |
Weak transcription |
iPS-18 Cell Line |
embryonic stem cell
|
13 |
chr2:182715200-182719600 |
Weak transcription |
Foreskin Melanocyte Primary Cells skin03 |
Skin
|
14 |
chr2:182715400-182716400 |
Enhancers |
Primary neutrophils fromperipheralblood |
blood
|
15 |
chr2:182715400-182716400 |
Enhancers |
Brain Anterior Caudate |
brain
|
16 |
chr2:182715400-182716800 |
Enhancers |
Primary hematopoietic stem cells |
blood
|
17 |
chr2:182715800-182716400 |
Enhancers |
H9 Derived Neuron Cultured Cells |
ES cell derived
|
18 |
chr2:182715800-182717000 |
Enhancers |
Brain Substantia Nigra |
brain
|
19 |
chr2:182716200-182716400 |
Flanking Active TSS |
Primary hematopoietic stem cells short term culture |
blood
|
20 |
chr2:182716200-182716400 |
Enhancers |
Fetal Stomach |
stomach
|
21 |
chr2:182716200-182716800 |
Enhancers |
Primary B cells from cord blood |
blood
|